Divergent synthesis of three classes of aryl N-glycosides by solvent control

Journal of Organic Chemistry

Volumn 74, Issue 2, 2009, Pages 685-695

  Zhang, Jianjun ^a   Chang, Cheng Wei Tom ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE DERIVATIVES; ARYL GLYCOSIDES; BIOLOGICAL APPLICATIONS; C-GLYCOSIDES; DIVERGENT SYNTHESIS; GLYCOSYL AZIDES; GLYCOSYLATED; HETEROCYCLIC COMPOUNDS; NAPHTHOQUINONE; O-GLYCOSIDES; POLAR SOLVENTS; SOLVENT CONTROLS;

ESTERIFICATION; GLYCOSYLATION; KETONES; NITROGEN COMPOUNDS; ORGANIC SOLVENTS; SOLVENTS; SYNTHESIS (CHEMICAL); TOLUENE;

SUGARS;

1 (1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE) 1 DIDEOXY DEXTRO MANNITOL; 1 (4 PIPERIDINYL) 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 (AMINOMETHYLENE 1,3 INDANEDIONE) 1 DIDEOXY DEXTRO MANNITOL; 1 [N (2 ACETAMIDO BETA DEXTRO GALACTOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (ALPHA DEXTRO FUCOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (ALPHA DEXTRO MANNOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (ALPHA DEXTRO RHAMNOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (BETA DEXTRO GALACTOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (BETA DEXTRO GLYCOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (BETA DEXTRO RIBOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N (BETA DEXTRO XYLOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N [4 O (BETA DEXTRO GALACTOPYRANOSYL)] BETA DEXTRO GLUCOPYRANOSYL] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N [4 O (BETA DEXTRO GLUCOPYRANOSYL)] BETA DEXTRO GLUCOPYRANOSYL] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1 [N [4 O [4 O (BETA DEXTRO GLUCOPYRANOSYL) BETA DEXTRO GLUCOPYRANOSYL) BETA DEXTRO GLUCOPYRANOSYL)] 1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE; 1,3 INDANDIONE DERIVATIVE; 1,4 NAPHTHOQUINONE; 1,6 BIS(1H NAPHTHO[2,3 D]TRIAZOLE 4,9 DIONE) 1,6 DIDEOXY DEXTRO MANNITOL; 2 [N (4 PIPERIDINYL)]AMINOMETHYLENE 1,3 INDANEDIONE; 2 [N (ALPHA DEXTRO RHAMNOPYRANOSYL)]AMINOMETHYLENE 1,3 INDANEDIONE; 2 [N (ALPHA DEXTRO XYLOPYRANOSYL)]AMINOMETHYLENE 1,3 INDANEDIONE; 2 [N (BETA DEXTRO GALACTOPYRANOSYL)]AMINOMETHYLENE 1,3 INDANEDIONE; 2 [N (BETA DEXTRO GLYCOPYRANOSYL)]AMINOMETHYLENE 1,3 INDANEDIONE; 2 [N (BETA DEXTRO RIBOPYRANOSYL)]AMINOMETHYLENE 1,3 INDANEDIONE; 2 [N (BETA DEXTRO XYLOPYRANOSYL)]AMINOMETHYLENE 1,3 INDANEDIONE; ANTHRAQUINONE DERIVATIVE; AZIDE; BENZAZEPINE DERIVATIVE; GLYCOSIDE; SOLVENT; TOLUENE; TX 1926; UNCLASSIFIED DRUG; MESYLIC ACID DERIVATIVE; NAPHTHOQUINONE; OXIDIZING AGENT; TRIFLUOROMETHANESULFONIC ACID TRIMETHYLSILYL ESTER; TRIMETHYLSILYL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRADING; CYCLOADDITION; DRUG SYNTHESIS; GLYCOSYLATION; HEATING; MITOCHONDRIAL RESPIRATION; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; RNA TRANSLATION; CHEMISTRY; SYNTHESIS;

AZIDES; GLYCOSIDES; MESYLATES; NAPHTHOQUINONES; OXIDANTS; SOLVENTS; TRIMETHYLSILYL COMPOUNDS;

EID: 60849100798     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo8020133     Document Type: Article

References (45)

1. Lednicer, D., Ed. Strategies for Organic Drug Synthesis and Design; John Wiley & Sons: New York, 1998.
2. Gringauz, A. Introduction to Medicinal Chemistry, How Drugs Act and Why?; Wiley-VCH: Weinheim, Germany, 1997.
3. Babu, K. S.; Li, X.-C.; Jacob, M. R.; Zhang, Q.; Khan, S. I.; Ferreira, D.; Clark, A. M. J. Med. Chem. 2006, 49, 7877-7886.
4. (a) Hori, H.; Nagasawa, H.; Ishibashi, M.; Uto, Y.; Hirata, A.; Saijo, K.; Ohkura, K.; Kirk, K. L.; Uehara, Y. Bioorg. Med. Chem. 2002, 10, 3257-3265.]
5. (b) Inayama, S.; Mamoto, K.; Shibata, T.; Hirose, T. J. Med. Chem. 1976, 19, 433-436.
6. Baut, L. et al. U.S. Patent No. 4,758,561.
7. Brase, S.; Gil, C.; Knepper, K. Bioorg. Med. Chem. 2002, 10, 2415-2437.
8. Kamal, A.; Reddy, K. L.; Devaiah, V.; Shankaraiah, N.; Reddy, D. R. Mini.-Rev. Med. Chem. 2006, 6, 53-69.
9. Guzikowski, A. P.; Cai, S. X.; Espitia, S. A.; Hawkinson, J. A.; Huettner, J. E.; Nogales, D. F.; Tran, M.; Woodward, R. M.; Weber, E.; Keana, J. F. W. J. Med. Chem. 1996, 39, 4643-4653.
10. Sum, F.-W.; Dusza, J.; Santos, E. D.; Grosu, G.; Reich, M.; Du, X.;
11. Albright, J. D.; Chan, P.; Coupet, J.; Ru, X.; Mazandaranib, H.; Saunders, T. Bioorg. Med. Chem. Lett. 2003, 13, 2195-2198.
12. For example: (a) Fan, E.; Shi, W.; Lowary, T. L. J. Org. Chem. 2007, 72, 2917-2928.
13. (b) Zhang, G.; Fang, L.; Zhu, L.; Zhong, Y.; Wang, P. G.; Sun, D. J. Med. Chem. 2006, 49, 1792-1799.
14. Wallace, K. B.; Starkov, A. A. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 353-388.
15. Sartori, M. F. Chem. Rev. 1962, 63, 279-296.
16. Wong, C.-H., Ed. Carbohydrate-Based Drug Discovery; Wiley-VCH: Weinheim, Germany, 2003.
17. Klyosov, A. A., Witczak, Z. J., Platt, D., Eds.; Carbohydrate-Based Drug Discovery; ACS Symposium Series; Vol. 932, 2005.
18. Demchenko, A., Ed.; Frontiers in Carbohydrate Chemistry; ACS Symposium Series; Vol. 960, 2007.
19. Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., Ed.; Wiley: New York, 1984; pp 1-176.
20. Zhang, J.; Chen, H.-N.; Chiang, F.-I.; Takemoto, J. Y.; Bensaci, M.; Chang, C.-W. T. J. Comb. Chem. 2007, 9, 17-19.
21. Zhang, J.; Garrossian, M.; Gardner, D.; Garrossian, A.; Chang, Y.-T.; Kim, Y. K.; Chang, C.-W. T. Bioorg. Med. Chem. Lett. 2008, 18, 1359-1363.
22. For examples of O-aryl glycosides, see: (a) Roush, W. R.; Lin, X.-F. J Org. Chem. 1991, 56, 5740-5742.
23. (b) Lam, S. N.; Gervay-Hague, J. Org. Lett. 2003, 5, 4219-4222.
24. For examples of C-aryl glycosides, see: (a) Hart, D. J.; Leroy, V.; Merriman, G. H.; Young, D. G. J. J. Org. Chem. 1992, 57, 670-5680.
25. (b) Palmacci, E. R.; Seeberger, P. H. Org. Lett. 2001, 3, 1547-1550.
26. (c) Toshima, K.; Matsuo, G.; Ishizuka, T.; Ushiki, Y.; Nakata, M.; Matsumura, S. J. Org. Chem. 1998, 63, 2307-2313.
27. (d) Hauser, F. M.; Hu, X. Org. Lett. 2002, 4, 977-978.
28. (e) Kaliappan, K. P.; Subrahmanyam, A. V. Org. Lett. 2007, 9, 1121-1124.
29. (f) Kaelin, D. E., Jr.; Sparks, S. M.; Plake, H. R.; Martin, S. F. J. Am. Chem. Soc. 2003, 125, 12994-12995.
30. (g) Chen, C.-L.; Sparks, S. M.; Martin, S. F. J. Am. Chem. Soc. 2006, 128, 13696-13697.
31. For examples of N-aryl glycosides, see: (a) Bridiau, N.; Benmansour, M.; Legoy, M. D.; Maugard, T. Tetrahedron 2007, 63, 4178-4183.
32. (b) Gama, Y.; Shibuya, I.; Shimizu, M. Chem. Pharm. Bull. 2002, 50, 1517-1519.
33. For example: (a) Bodnar, B. S.; Miller, M. J. J. Org. Chem. 2007, 72, 3929-3932.
34. (b) Brase, S.; Gil, C.; Knepper, K.; Zimmermann, V. Angew. Chem., Int. Ed. 2005, 44, 5188-5240.
35. (c) Tarabara, I. N.; Kasyan, A. O.; Yarovoi, M. Y.; Shishkina, S. V.; Shishkin, O. V.; Kas'yan, L. I. Russ. J. Org. Chem. 2004, 40, 992-998.
36. Schultz, A. G.; McMahon, W. G. J. Org. Chem. 1984, 49, 1676-1678.
37. Reddy, D. S.; Judd, W. R.; Aube, J. Org. Lett. 2003, 5, 3899-3902.
38. Logothetis, A. L. J. Am. Chem. Soc. 1965, 87, 749-754.
39. Scheiner, P. J. Am. Chem. Soc. 1968, 90, 988-992.
40. Stout, D. M.; Takaya, T.; Meyers, A. I. J. Org. Chem. 1975, 40, 563-569.
41. With the exception of 15m and 17m, the separation of 15/17 mixture proves to be challenging. However, for the acetylation of the mixture followed by aqueous workup, we were amazed to discover that only the 17 component was present in organic solution. Further purification of 17 by recrystallization offered the pure desired products.
42. Among the samples, 19a, 19d, 19f, 19k, 19m, submitted for one-dose assay, 19f and 19k were selected for further five-dose testing. Please refer to Supporting Information for more details.
43. Harmon, R. E.; Earl, R. A.; Gupta, S. K. J. Org. Chem. 1971, 36, 2553-2556.
44. Joosten, J. A. F.; Tholen, N. T. H.; Maate, F. A. E.; Brouwer, A. J.; van Esse, G. W.; Rijkers, D. T. S.; Liskamp, R. M. J.; Pieters, R. J. Eur. J. Org. Chem. 2005, 3182-3185.
45. Alonso, G.; Garcia-Lopez, M. T.; Garcia-Munoz, G.; Madronero, R.; Rico, M. J. Heterocycl. Chem. 1970, 7, 1269-1272.